{
  "id": 21053964,
  "title": "Despite soaring demand for GLP-1s, many eligible patients are unable to access these drugs for weight loss",
  "url": "https://urgent.news/2026/11/21/despite-soaring-demand-for-glp-1s-many-eligible-patients-are-unable",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-21T14:00:01.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-11-soaring-demand-glp-1s-eligible.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "In just a few short years, glucagon-like peptide-1 (GLP-1) receptor agonists have surged in popularity across the United States, transforming from specialized treatments for type 2 diabetes into revolutionary therapeutics for weight management, cardiovascular health and other emerging uses. But not all populations are benefiting from this expansion. As GLP-1 use has increased, disparities in…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}